3 Biotech Stocks With Major Catalysts in January

This January is going to be a big month for folks with fatty liver disease or need of a COVID-19 vaccine. It's also going to be a month of ups or downs for shareholders of some volatile biotech stocks.

Intercept Pharmaceuticals (NASDAQ: ICPT) and Madrigal Pharmaceuticals (NASDAQ: MDGL) have important clinical trial readouts expected this month. After an excruciatingly long wait, Novavax (NASDAQ: NVAX) could also announce some important progress with its COVID-19 vaccine.

Here's what investors want to know about upcoming binary events that could send these biotech stocks rocketing higher, or cause them to sink like a stone.

Continue reading

Source Fool.com